Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Serenity Pharmaceuticals" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Serenity Pharmaceuticals for you to read. Along with our medical data and news we also list Serenity Pharmaceuticals Clinical Trials, which are updated daily. BioPortfolio also has a large database of Serenity Pharmaceuticals Companies for you to search.
(MedPage Today) -- Adaptation and serenity have worked for millennia
In time for the holidays, the alcohol and drug detox providers together invested £100,000 into a drink and driving program. UNITED KINGDOM (PRWEB) December 24, 2018 The festive season finds many behind the wheel while under the influence across the United Kingdom. Knowing the seriousness of driving while drinking or using drugs, Serenity Addiction Centres and Steps Counselling has joined tog...
Sunspire Health Texas, a community-based addiction treatment center which is part of the Meadows Behavioral Healthcare network of nationwide specialized behavioral healthcare programs, is excited to announce that, effective immediately, it will be known as Serenity View Recovery Center. As Serenity View Recovery Center, the facility will continue to offer ...
The products in question are three natural sleep aids, named "Blissful Sleep", "Blissful Sleep Ex" and "Skullcap Serenity".
AMELIA ISLAND, Fla. (PRWEB) December 14, 2018 In an effort to further enhance its holistic wellness experience resort-wide, The Ritz-Carlton, Amelia Island will expand its platforms emphasizing mindfulness, serenity and healthy living by introducing quarterly wellness retreats with acclaimed...
AMAG Pharmaceuticals said today it has agreed to acquire Perosphere Pharmaceuticals for up to $415 million, in a deal that the buyer said will expand its pipeline, and especially its presence in hematology with Perosphere’s next-generation anticoagulant reversal candidate ciraparantag (PER977). Ciraparantag is an intravenously-administered synthetic small molecule anticoagulant reversal agen...
Aridis Pharmaceuticals has raised $26m through an initial public offering of two million shares of its common stock priced at $13...Read More... The post Deals and M&As this week: Aridis Pharmaceuticals, Xeris Pharmaceuticals, Astellas Pharma appeared first on Drug Development Technology.
Edison Investment Research - Pharmaceuticals & healthcare - InMed Pharmaceuticals: InMed recently reported results for the second quarter of FY19 and is on track to bring INM-750 for epidermolysis ...
VIENNA, Austria, Aug. 28, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the development and commercialization of cannabinoid prescr...
ACADIA Pharmaceuticals (NASDAQ:ACAD) and Neuren Pharmaceuticals (ASX:NEU) announced today that they have entered into an exclusive North American License Agreement for the development and commercialization of trofinetide for Rett syndrome and other indications. Neuren retains rights to develop and commercialize trofinetide for all indications outside of North America. As quoted in the press releas...
Barry Labinger has joined Checkmate Pharmaceuticals as president and CEO, the Cambridge, MA, company announced Wednesday. Labinger comes to the cancer drug developer from Biothera Pharmaceuticals, where he was president and CEO. His experience also includes leadership positions at Human Genome Sciences, 3M Pharmaceuticals, and Immunex. Labinger is succeeding Arthur Krieg, who is shifting to [̷...
MELBOURNE, Australia, BRUSSELS and LIÈGE, Belgium, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) ("Telix", the "Company"), a clinical-stage biopharmaceutical company foc...
NewsUpon closing of the Proposed Transaction, Nuvo would pay Aralez $110 million in cash,
Astellas Pharma has completed the acquisition of Potenza Therapeutics for $405m. Astellas made an upfront payment of $164.6m and has...Read More... The post M&As this week: Astellas Pharma, Taisho Pharmaceuticals, AMAG Pharmaceuticals appeared first on Pharmaceutical Tech
Amicus Therapeutics has entered a collaboration with the Perelman School of Medicine at the University of Pennsylvania to develop new...Read More... The post Deals this week: Amicus Therapeutics, Janssen Pharmaceuticals, Ionis Pharmaceuticals appeared first on Pharmaceutical Technology.
AMAG Pharmaceuticals, Inc. has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc, a private biopharmaceutical company.
Canada-based Bausch Health Companies (previously Valeant Pharmaceuticals) has entered into a definitive agreement to acquire select assets of Synergy Pharmaceuticals...Read More... The post Bausch Health makes $200m bid for bankrupt Synergy Pharmaceuticals appeared first on Pharmaceutical Technology.
WESTON, Fla., Aug. 27, 2018 /PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals for the treatment of cancer, today announced that the U.S. Food and Drug Administration...
Edison Investment Research - Pharmaceuticals & healthcare - Sunesis Pharmaceuticals: In January 2019 Sunesis announced that its Phase Ib/II study of vecabrutinib for B-cell cancers advanced to the ...
NewsUnder the terms of the Proposed Transaction, Nuvo would acquire Aralez's Canadian specialty pharmaceutical business.
Canada-based Aralez Pharmaceuticals has completed the divestment of more than 20 medicines under its portfolio to Nuvo Pharmaceuticals for a...Read More... The post Aralez completes sale of drug rights to Nuvo Pharmaceuticals for $110m appeared first on Pharmaceutical Technology.
SAN DIEGO, CA / ACCESSWIRE / August 21, 2018 / Emerald Health Pharmaceuticals Inc. (EHP), a company developing medicines based on cannabinoid science, today announced that Carmen Navarrete, Ph.D., ...
Next Generation Anticoagulant Reversal Agent, Ciraparantag, Will Add Innovative Clinical Stage Asset to AMAG’s Hematology Portfolio Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc., a private biopha...
December 11 – 12, 2018 Workshops, December 10, 2018 The Revere Hotel 200 Stuart St., Boston, MA SVP R&D leading workshop on Financial Planning and Commercial DevelopmentSVP R&D to present A Translational R&D Program with Dronabinol for OSACFO participating on panel on Funding the Commercial Development of Pharmaceutical Cannabinoids Glen Rock, N.J., Dec. 10, 2018 (GLOBE NEW...
India-based Glenmark Pharmaceuticals is set to spin-off its innovation business into a new company in the US to increase focus...Read More... The post Glenmark Pharmaceuticals to establish new company in US appeared first on Pharmaceutical Technology.